Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 20, 2015 - Issue 4
Submit an article Journal homepage
476
Views
4
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for the treatment of myelofibrosis

Holly L GeyerMayo Clinic, Department of Hospital Internal Medicine, 13400 E Shea Blvd, AZ, USA
, MD (Assistant Professor of Medicine) &
Ruben A MesaMayo Clinic, Division of Hematology and Oncology, Department of Hematology and Medical Oncology, 13400 E Shea Blvd, Scottsdale, AZ, USA+1 480 301 8335; +1 480 301 4675; [email protected]
, MD (Professor of Medicine)
Pages 663-678 | Published online: 08 Jul 2015

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Prithviraj Bose & Srdan Verstovsek. (2016) Investigational histone deacetylase inhibitors (HDACi) in myeloproliferative neoplasms. Expert Opinion on Investigational Drugs 25:12, pages 1393-1403.
Read now

Articles from other publishers (3)

Lindsey Shantzer, Kristin Berger & Jeffrey J. Pu. (2016) Primary myelofibrosis and its targeted therapy. Annals of Hematology 96:4, pages 531-535.
Crossref
Naveen Pemmaraju, Audun Utengen, Vikas Gupta, Jean-Jacques Kiladjian, Ruben Mesa & Michael A. Thompson. (2016) Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM. Current Hematologic Malignancy Reports 11:6, pages 456-461.
Crossref
Karl Haslam & Stephen E. Langabeer. (2016) Monitoring Minimal Residual Disease in the Myeloproliferative Neoplasms: Current Applications and Emerging Approaches. BioMed Research International 2016, pages 1-6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.